¿Cuáles son los estados financieros clave de Stella Diagnostics Inc?
¿Cuáles son los ratios financieros clave para SLDX?
¿Cómo se desglosan los ingresos de Stella Diagnostics Inc por segmento o geografía?
¿Es rentable Stella Diagnostics Inc?
¿Tiene Stella Diagnostics Inc alguna deuda?
¿Cuántas acciones en circulación tiene Stella Diagnostics Inc?
Estadísticas clave
Cierre Anterior
$0.0155
Precio de apertura
$0.014
Rango del día
$0.014 - $0.0154
Rango de 52 semanas
$0.0111 - $0.0585
Volumen
20
Volumen promedio
539
EPS (TTM)
--
Rendimiento de dividendos
--
Cap. de mercado
$1.5M
¿Qué es SLDX?
Stella Diagnostics, Inc. operates as a molecular diagnostics-based organization, which focuses on improving patient management strategies. The company is headquartered in Salt Lake City, Utah. The company went IPO on 2003-07-29. The Company’s proprietary technology is based on rigorous research by domain experts and practicing physicians and can notify providers if common diseases of the esophagus like GERD and Barrett’s esophagus express proteins associated with normal or carcinogenic processes. Its panel of biomarkers and targeted proteomics method, the company can better inform gastroenterologists, surgical oncologists and pathologists which patients are high risk for disease progression into precancer or cancer. The predictive panel will be offered as a Laboratory Developed Test (LDT) in a CAP/CLIA Certified moderate complexity laboratory. Its subsidiaries include SLDX, Inc. and Galaxy Pharmaceuticals LLC.